Publications

Buhrmann C, Popper B, Kunnumakkara AB, Aggarwal BB and Shakibaei M (2019). Evidence that calebin A, a component of Curcuma longa suppresses NF-κB mediated proliferation, invasion and metastasis of human colorectal cancer induced by TNF-β (Lymphotoxin). Nutrients, 11(2), 2904; doi:10.3390/nu11122904

Buhrmann C, Kunnumakkara AB, Popper B, Majeed M, Aggarwal BB and Shakibaei M (2020). Calebin A potentiates the effect of 5-FU and TNF-β (lymphotoxin α) against human colorectal cancer cells: Potential role of NF-κB. International Journal of Molecular Sciences, 21(7), 2393

Goenka S, Nagabhushanam K, Majeed M and Simon SR (2019). Calebin-A, a curcuminoid analog inhibits α-MSH-induced melanogenesis in B16F10 mouse melanoma cells. Cosmetics, 6(3), 51

Lai CS, Liao SN, Tsai ML, Kalyanam N, Majeed M, Majeed A, Ho CT and Pan MH. (2015). Calebin‐A inhibits adipogenesis and hepatic steatosis in high‐fat diet‐induced obesity via activation of AMPK signaling. Molecular Nutrition & Food Research, 59(10), 1883-1895

Lee P-S, Lu Y-Y, Nagabhushanam K, Ho C-T, Mei H-C and Pan M-H (2022). Calebin-A prevents HFD-induced obesity in mice by promoting thermogenesis and modulating gut microbiota. Journal of Traditional and Complementary Medicine, doi.org/10.1016/j.jtcme.2022.01.001

Majeed A, Majeed M, Thajuddin N, Arumugam S, Ali F and Beede K (2019). Biotransformation of curcumin to calebin-A: A pharmacologically important novel curcuminoid from curcuma species. Journal of Pure and Applied Microbiology, 13(2), 1159-1168

Majeed A, Majeed M, Thajuddin N, Arumugam S, Ali F, Beede K, Adams SJ and Gnanamani M (2019). Bioconversion of curcumin into calebin-A by the endophytic fungus Ovatospora brasiliensis EPE-10 MTCC 25236 associated with Curcuma caesia. AMB Express, 9(1), 1-13

Majeed A, Nagabhushanam K, Majeed M, Thomas SM and Thajuddin N (2017). An expeditious, green and protecting-group-free synthesis of a potent secondary metabolite calebin-A and its analogues. Georg Thieme Verlag Stuttgart · New York — SynOpen, 1, 125-128

Majeed M, Majeed A, Pandey A, Lad PS and Vuppala KK (2016). Efficacy and tolerability of a novel formulation for weight management in obese subjects: A randomized, double blind, placebo controlled, clinical study. International Journal of Ayurveda and Pharma Research, 4(11), 10-17

Majeed M, Nagabhushanam K, Natarajan S, Bani S, Pandey A and Karri SK (2015). Investigation of repeated dose (90 day) oral toxicity, reproductive/developmental toxicity and mutagenic potential of ‘Calebin A’. Toxicology Reports, 2, 580-589

Novaes JT, Lillico R, Sayre CL, Nagabushanam K, Majeed M, Chen Y, Ho EA, Oliveira ALDP, Martinez SE, Alrushaid S, Davies NM and Lakowski TM (2017). Disposition, metabolism and histone deacetylase and acetyltransferase inhibition activity of tetrahydrocurcumin and other curcuminoids. Pharmaceutics, 9(4), 45

Oliveira ALDP, Martinez SE, Nagabushnam K, Majeed M, Alrushaid S, Sayre CL and Davies NM (2015). Calebin A: Analytical development for pharmacokinetics study, elucidation of pharmacological activities and content analysis of natural health products. Journal of Pharmacy & Pharmaceutical Sciences, 18(4), 494-514

Pan MH, Chiou YS, Kalyanam N, Ho CT and Ding B (2017). Preparation of calebin-A liposomes and its antiproliferation in human cancer cells. Journal of Analytical and Pharmaceutical Research, 5(2), 00137. doi: 10.15406/japlr.2017.05.00137

Tyagi AK, Prasad S, Majeed M and Aggarwal BB (2016). Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling. Archives of Biochemistry and Biophysics, 593, 80-89

Tyagi AK, Prasad S, Majeed M and Aggarwal BB (2017). Calebin A, a novel component of turmeric, suppresses NF-κB regulated cell survival and inflammatory gene products leading to inhibition of cell growth and chemosensitization. Phytomedicine, 34, 171-181